Vixiar Medical Inc., a privately held company in Baltimore focused on noninvasive devices and systems for monitoring cardiopulmonary diseases, closed its most recent financing of $1.5 million from new and existing investors. Proceeds will be used to complete an ongoing clinical trial and to prepare regulatory submissions.